Fennec Pharmaceuticals (FENC) Change in Accured Expenses (2014 - 2025)
Fennec Pharmaceuticals posted quarterly Change in Accured Expenses of $1.9 million for Q4 2025, up 1581.74% year-on-year from $115000.0 in Q4 2024, and up 31.03% on a QoQ basis from $1.5 million in Q3 2025.
Fennec Pharmaceuticals (FENC) has 12 years of Change in Accured Expenses data on file, last reported at $1.9 million in Q4 2025.
- For the quarter ending Q4 2025, Change in Accured Expenses rose 1581.74% year-over-year to $1.9 million; the trailing twelve-month figure through Dec 2025 stood at $2.2 million (up 776.99% YoY), and the FY2025 full-year result was $2.2 million, up 776.99% from the prior year.
- Change in Accured Expenses for Q4 2025 stood at $1.9 million, up from $1.5 million in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $1.9 million in Q4 2025 and bottomed at -$1.3 million in Q2 2024.
- The 5-year median for Change in Accured Expenses is -$29000.0 (2021), against an average of $195000.0.
- The widest annual swing landed in 2022, when Change in Accured Expenses soared 10635.29%; it then sank 1666.67% in 2024.
- A 5-year view of Change in Accured Expenses shows it stood at $17000.0 in 2021, then jumped by 10635.29% to $1.8 million in 2022, then rose by 1.1% to $1.8 million in 2023, then tumbled by 93.77% to $115000.0 in 2024, then surged by 1581.74% to $1.9 million in 2025.
- The last three Change in Accured Expenses figures came in at $1.9 million (Q4 2025), $1.5 million (Q3 2025), and -$618000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 931,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 70.50 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 107.70 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -176.03 Mn |
| 10 | Fennec Pharmaceuticals | 281.48 Mn | 244.70 Mn | 7.67 Mn | 1.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.93 Mn |
| Dec 31, 2025 | 1.93 Mn |
| Sep 30, 2025 | 1.48 Mn |
| Sep 30, 2025 | 1.48 Mn |
| Jun 30, 2025 | -618,000.00 |
| Jun 30, 2025 | -618,000.00 |
| Mar 31, 2025 | -585,000.00 |
| Mar 31, 2025 | -585,000.00 |
| Dec 31, 2024 | 115,000.00 |
| Dec 31, 2024 | 115,000.00 |
| Sep 30, 2024 | 275,000.00 |
| Sep 30, 2024 | 275,000.00 |
| Jun 30, 2024 | -1.33 Mn |
| Jun 30, 2024 | -1.33 Mn |
| Mar 31, 2024 | 609,000.00 |
| Mar 31, 2024 | 609,000.00 |
| Dec 31, 2023 | 1.85 Mn |
| Dec 31, 2023 | 1.85 Mn |
| Sep 30, 2023 | -270,000.00 |
| Sep 30, 2023 | -270,000.00 |
| Jun 30, 2023 | -75,000.00 |
| Jun 30, 2023 | -75,000.00 |
| Mar 31, 2023 | -924,000.00 |
| Mar 31, 2023 | -924,000.00 |
| Dec 31, 2022 | 1.83 Mn |
| Dec 31, 2022 | 1.83 Mn |
| Sep 30, 2022 | 100,000.00 |
| Sep 30, 2022 | 100,000.00 |
| Jun 30, 2022 | -118,000.00 |
| Jun 30, 2022 | -118,000.00 |
| Mar 31, 2022 | -465,000.00 |
| Mar 31, 2022 | -465,000.00 |
| Dec 31, 2021 | 17,000.00 |
| Dec 31, 2021 | 17,000.00 |
| Sep 30, 2021 | 689,000.00 |
| Sep 30, 2021 | 689,000.00 |
| Jun 30, 2021 | -213,000.00 |
| Jun 30, 2021 | -213,000.00 |
| Mar 31, 2021 | -392,000.00 |
| Mar 31, 2021 | -392,000.00 |
| Dec 31, 2020 | 167,000.00 |
| Dec 31, 2020 | 167,000.00 |
| Sep 30, 2020 | -55,000.00 |
| Sep 30, 2020 | -55,000.00 |
| Jun 30, 2020 | 24,000.00 |
| Jun 30, 2020 | 24,000.00 |
| Mar 31, 2020 | -427,000.00 |
| Mar 31, 2020 | -427,000.00 |
| Dec 31, 2019 | 542,000.00 |
| Dec 31, 2019 | 542,000.00 |
| Sep 30, 2019 | -8,000.00 |
| Sep 30, 2019 | -8,000.00 |
| Jun 30, 2019 | -28,000.00 |
| Jun 30, 2019 | -28,000.00 |
| Mar 31, 2019 | -452,000.00 |
| Mar 31, 2019 | -452,000.00 |
| Dec 31, 2018 | 395,000.00 |
| Dec 31, 2018 | 395,000.00 |
| Sep 30, 2018 | 72,000.00 |
| Sep 30, 2018 | 72,000.00 |
| Jun 30, 2018 | -2,000.00 |
| Jun 30, 2018 | -2,000.00 |
| Mar 31, 2018 | -482,000.00 |
| Mar 31, 2018 | -482,000.00 |
| Dec 31, 2017 | 457,000.00 |
| Dec 31, 2017 | 457,000.00 |
| Sep 30, 2017 | 71,000.00 |
| Sep 30, 2017 | 71,000.00 |
| Jun 30, 2017 | -38,000.00 |
| Jun 30, 2017 | -38,000.00 |
| Mar 31, 2017 | 7,000.00 |
| Mar 31, 2017 | 7,000.00 |
| Dec 31, 2016 | 37,000.00 |
| Dec 31, 2016 | 37,000.00 |
| Sep 30, 2016 | 38,000.00 |
| Sep 30, 2016 | 38,000.00 |
| Jun 30, 2016 | -31,000.00 |
| Jun 30, 2016 | -31,000.00 |
| Mar 31, 2016 | -11,000.00 |
| Mar 31, 2016 | -11,000.00 |
| Dec 31, 2015 | 6,000.00 |
| Dec 31, 2015 | 6,000.00 |
| Sep 30, 2015 | 37,000.00 |
| Sep 30, 2015 | 37,000.00 |
| Jun 30, 2015 | 4,000.00 |
| Jun 30, 2015 | 4,000.00 |
| Mar 31, 2015 | -87,000.00 |
| Mar 31, 2015 | -87,000.00 |
| Dec 31, 2014 | 94,000.00 |
| Dec 31, 2014 | 94,000.00 |
| Sep 30, 2014 | 2,000.00 |
| Sep 30, 2014 | 2,000.00 |
| Jun 30, 2014 | -21,000.00 |
| Jun 30, 2014 | -21,000.00 |
| Mar 31, 2014 | -75,000.00 |
| Mar 31, 2014 | -75,000.00 |